Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
LabCorp (LH) Q1 Earnings Surpass Estimates, Revenues Miss
12:47pm, Thursday, 28'th Apr 2022
LabCorp (LH) reports better-than-expected earnings for the first quarter, with robust sales within the Drug Development arm driving the top line.
LabCorp (LH) Surpasses Q1 Earnings Estimates
12:05pm, Thursday, 28'th Apr 2022 Zacks Investment Research
LabCorp (LH) delivered earnings and revenue surprises of 3.91% and 3.49%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
LabCorp (LH) Surpasses Q1 Earnings Estimates
09:49am, Thursday, 28'th Apr 2022
LabCorp (LH) delivered earnings and revenue surprises of 3.91% and 3.49%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Stocks' Earnings on Apr 28: TMO, BIO & More
02:52pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Medical Products companies' results are likely to reflect a rebound in the base business. Let's see how TMO, BIO, LH and RMD fare this time.
Medical Products Stocks' Earnings on Apr 28: TMO, BIO & More
12:18pm, Wednesday, 27'th Apr 2022
Medical Products companies' results are likely to reflect a rebound in the base business. Let's see how TMO, BIO, LH and RMD fare this time.
Expert Ratings for Laboratory Corp
06:12pm, Monday, 25'th Apr 2022 Benzinga
Within the last quarter, Laboratory Corp (NYSE:LH) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
1
0
0
Last 30D
LabCorp (LH) to Report Q1 Earnings: What's in the Cards?
03:22pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Robust base business growth and notable launches are likely to have contributed to LabCorp's (LH) Q1 performance.
LabCorp (LH) Stock Moves -0.57%: What You Should Know
09:50pm, Thursday, 21'st Apr 2022 Zacks Investment Research
LabCorp (LH) closed the most recent trading day at $276.30, moving -0.57% from the previous trading session.
Analysts Estimate LabCorp (LH) to Report a Decline in Earnings: What to Look Out for
07:01pm, Thursday, 21'st Apr 2022 Zacks Investment Research
LabCorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LabCorp (LH) Gains But Lags Market: What You Should Know
10:00pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
LabCorp (LH) closed at $271.14 in the latest trading session, marking a +1.5% move from the prior day.
Labcorp initiates dividend, with an initial implied yield above 1%
07:19am, Thursday, 07'th Apr 2022
Laboratory Corp. of America Holdings LH, +0.24% , also known as Labcorp, said Thursday that it has initiated a quarterly dividend of 72 cents a share. Shareholders of record on May 19 will be paid the
LabCorp (LH) Gains As Market Dips: What You Should Know
09:50pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
LabCorp (LH) closed the most recent trading day at $264.88, moving +0.24% from the previous trading session.
LabCorp (LH) Dips More Than Broader Markets: What You Should Know
09:50pm, Thursday, 31'st Mar 2022 Zacks Investment Research
LabCorp (LH) closed the most recent trading day at $263.66, moving -1.99% from the previous trading session.
IHF: A Standout Performer With Strong Future Growth Prospects
02:38pm, Wednesday, 30'th Mar 2022
IHF: A Standout Performer With Strong Future Growth Prospects
LabCorp (LH) Gains From Covance Arm Growth, Cost Pressure Ails
02:24pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
LabCorp's (LH) Covance Drug Development arm is benefiting from its collaborations with leading pharmaceutical and biotechnology companies.
